Skip to main content

LAWSUITS FILED AGAINST GSX, IQ and CCL - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS

NEW YORK, NY / ACCESSWIRE / June 5, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

GSX Techedu Inc. (NYSE:GSX)

CONTACT JAKUBOWITZ ABOUT GSX:
https://claimyourloss.com/securities/gsx-techedu-inc-loss-submission-form/?id=7173&from=1

Class Period : June 6, 2019 - April 13, 2020

Lead Plaintiff Deadline : June 16, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) GSX overstated its profitability, revenue, student enrollment figures, teacher qualifications, and teacher selection process; (ii) the foregoing, once revealed, was foreseeably likely to have a material negative impact on the Company's financial results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

iQIYI, Inc. (NASDAQ:IQ)

CONTACT JAKUBOWITZ ABOUT IQ:
https://claimyourloss.com/securities/iqiyi-inc-loss-submission-form/?id=7173&from=1

The IQ lawsuit is on behalf of persons and entities other than Defendants that purchased or otherwise acquired: (a) iQIYI American Depository Shares pursuant and/or traceable to the Company's initial public offering conducted on or about March 29, 2018; or (b) iQIYI securities between March 29, 2018, and April 7, 2020.

Lead Plaintiff Deadline : June 15, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) iQIYI inflated its revenue figures; (2) iQIYI inflated its user numbers; (3) iQIYI inflated its expenses to cover up other fraud; and (4) as a result, Defendants' public statements were materially false and misleading at all relevant times.

Carnival Corporation & Plc (NYSE:CCL)

CONTACT JAKUBOWITZ ABOUT CCL:
https://claimyourloss.com/securities/carnival-corporation-loss-submission-form/?id=7173&from=1

Class Period : January 28, 2020 - May 1, 2020

Lead Plaintiff Deadline : July 27, 2020

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's medics were reporting increasing events of COVID-19 illness on the Company's ships; (2) Carnival was violating port of call regulations by concealing the amount and severity of COVID-19 infections on board its ships; (3) in responding to the outbreak of COVID-19, Carnival failed to follow the Company's own health and safety protocols developed in the wake of other communicable disease outbreaks; (4) by continuing to operate, Carnival ships were responsible for continuing to spread COVID-19 at various ports throughout the world; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887

SOURCE: Jakubowitz Law



View source version on accesswire.com:
https://www.accesswire.com/592887/LAWSUITS-FILED-AGAINST-GSX-IQ-and-CCL--JAKUBOWITZ-LAW-PURSUES-SHAREHOLDERS-CLAIMS

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.